Business
Press Release Mar 10 2023
Natco Pharma Limited has informed the Exchange regarding a press release dated March 10, 2023, titled "NATCO announces the Launch of additional strengths for the Generic Version of Revlimid�� (lenalidomide capsules), in the USA".
About this update from Natco Pharma Limited
Natco Pharma Limited has informed the Exchange regarding a press release dated March 10, 2023, titled "NATCO announces the Launch of additional strengths for the Generic Version of Revlimid�� (lenalidomide capsules), in the USA". View Attachment
View stock analysis, news, and events for Natco Pharma Limited